Kevin S. Boyle Sr.
Chief Executive Officer at Alaunos Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Alaunos Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Alaunos Therapeutics Inc. June 6, 202382.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 1, 2023 | Alaunos Therapeutics Inc. | Open-market sale | −68,014 | $0.14 | $9,522 |
Questions about Kevin S. Boyle Sr.
What boards is Kevin S. Boyle Sr. on?
Kevin S. Boyle Sr. sits on the board of Alaunos Therapeutics Inc.
Has Kevin S. Boyle Sr. been a CEO?
Yes — Kevin S. Boyle Sr. was CEO of Alaunos Therapeutics Inc. (Until December 2023).
How long has Kevin S. Boyle Sr. served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.